The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Trusova N.A.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva

Levin O.S.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia

Arablinskiĭ A.V.

Otdel luchevoĭ diagnostiki gorodskoĭ klinicheskoĭ bol'nitsy im. S.P. Botkina, Moskva

Clinical and neuropsychological features of Alzheimer’s disease in the combination with cerebrovascular disease

Authors:

Trusova N.A., Levin O.S., Arablinskiĭ A.V.

More about the authors

Read: 2384 times


To cite this article:

Trusova NA, Levin OS, Arablinskiĭ AV. Clinical and neuropsychological features of Alzheimer’s disease in the combination with cerebrovascular disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(6‑2):46‑53. (In Russ.)
https://doi.org/10.17116/jnevro20161166246-53

Recommended articles:
Cyto­kine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
A comprehensive study of Alzheimer’s disease biomarkers in plasma and cere­brospinal fluid. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):43-53
Prospects for treating Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):54-60
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124
Novel prospects for early diagnosis of cognitive impairment using Eye-tracking technology. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):13-20
Features of facial expressions in patients with cognitive impairment due to Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):104-109
Diagnosis of Alzheimer’s disease using biological markers in corticobasal syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):133-139

References:

  1. Levin O.S. Diagnostika i lechenie dementsii v klinicheskoi praktike. 3-e izd. M: MEDpress-inform; 2012.
  2. Yakhno N.N. Bolezn' Al'tsgeimera: klinika, patogenez, lechenie. Russkii meditsinskii zhurnal. 2006;9:641-646.
  3. Gavrilova S.I., Levin O.S., Zhdaneeva L.V. Nevrologicheskie narusheniya pri bolezni Al'tsgeimera. Zhurnal nevrologii i psikhiatrii.im. S.S. Korsakova. 2010;110:7:4-8.
  4. Schneider J, Arvanitakis Z, Bang W, Bennett D. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197-2204. doi: 10.1212/01.wnl.0000271090.28148.24
  5. Konferentsiya «Aktual'nye problemy geriatricheskoi psikhiatrii». 19 noyabrya, 2012. Moskva. Ssylka aktivna na 29.06.16. Dostupno po: http://www.eecmedical.ru/news/30/?lang=ru
  6. Jellinger K. Prevalence and impact of cerebrovascular lesions in Alzheimer and Lewy body diseases. Neurodegener Dis. 2010;7:112-115. doi: 10.1159/000285518
  7. Jellinger K, Attems J. Neuropathological evaluation of mixed dementia. JNeurol Sci. 2007;257:80-87. doi: 10.1016/j.jns.2007.01.045
  8. Zekry D, Hauw J, Gold G. Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc. 2002;50:1431-1438. doi: 10.1046/j.1532-5415.2002.50367.x
  9. Attems J, Jellinger K. The overlap between vascular disease and Alzheimer’sdisease - lessons from pathology. BMS Medicine. 2014;12:206-217. doi: 10.1186/s12916-014-0206-2
  10. Chui H, Ramirez-Gomez L. Clinical and imaging features of mixed Alzheimer and vascular pathologies. Alzheimers Res Ther. 2015;7(1):1-13. doi: 10.1186/s13195-015-0104-7
  11. Levin O.S. Diagnostika i lechenie smeshannoi dementsii. Pozhiloi patsient. 2010;2:14-20.
  12. Levin O.S., Trusova N.A. Sosudistye faktory riska bolezni Al'tsgeimera. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;113(7):3-12.
  13. Jellinger K. Pathology and pathogenesis of vascular cognitive impairment - a critical update. Front Aging Neurosci. 2013;5:17. doi: 10.3389/fnagi.2013.00017
  14. Yarchoan M, Xie S, Kling M, Toledo J. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain. 2012;135(12): 3749-3756. doi: 10.1093/brain/aws271
  15. Zlokovic B. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Neuroscience. 2011;12:723-738. doi: 10.1038/nrn3114
  16. Breteler M, van Swieten J, Bots M et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population based study: the Rotterdam Study. Neurol. 1994;44:1246-1252. doi: 10.1212/wnl.44.7.1246
  17. Kudo T, Imaizumi K et al. Are cerebrovascular factors involved in Alzheimer’s disease? Neurobiol Aging. 2000;21:215-224. doi: 10.1016/s0197-4580(00)00129-9
  18. Ferstl Kh., Melike A., Vaikhel' K. Dementsiya. Per. s nem. M.: MEDpress-inform; 2010.
  19. Bruandet A, Richard F, Bombois S et al. Alzheimer's disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry. 2009;80:133-139. doi: 10.1136/jnnp.2007.137851
  20. Leys D, Henon H, Mackowiak-Cordoliani M, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4(11):752-759. doi: 10.1016/s1474-4422(05)70221-0
  21. Levin O.S., Usol'tseva N.I., Yunishchenko N.A. Postinsul'tnye kognitivnye narusheniya: mekhanizmy razvitiya i podkhody k lecheniyu. Trudnyi patsient. 2007;5(8):37-43.
  22. Kalaria R. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev. 2010;68(2):74-87. doi: 10.1111/j.1753-4887.2010.00352.x
  23. Lo R, Jagust W. Vascular burden and Alzheimer's disease pathologic progression. Neurol. 2012;79(13):1349-1355. doi: 10.1212/wnl.0b013e31826c1b9d
  24. de Leeuw F, Korf E, Barkhof F, Scheltens P. White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer's disease. Stroke. 2006;37(9):2248-2252. doi: 10.1161/01.str.0000236555.87674.e1
  25. Kim H, Cha J, Lee J et al. Distinctive Resting State Network Disruptions Among Alzheimer’s Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients. J Alzheimers Dis. 2016;50(3):709-718. doi: 10.3233/jad-150637
  26. Olazarán J, Navarro E, Rojo J. Alzheimer’s Disease with Vascular Component: A Distinct Clinical Entity? Dement Geriatr Cogn Dis Extra. 2012;2(1):400-410. doi: 10.1159/000342346
  27. Chui H, Zarow C, Mack W. Cognitive impact of subcortical vascular and Alzheimer’s disease pathology. Ann Neurol. 2006;60(6):677-687. doi: 10.1002/ana.21009
  28. Sinka L, Kövari E, Gold G, Hof P, Herrmann F, Bouras C, Giannakopoulos P. Small vascular and Alzheimer disease-related pathologic determinants of dementia in the oldest-old. J Neuropathol Exp Neurol. 2010;69(12):1247-1255. doi: 10.1097/nen.0b013e3181ffc3b9
  29. Levin O.S. Kliniko-magnitnorezonansno-tomograficheskoe issledovanie distsirkulyatornoi entsefalopatii s kognitivnymi narusheniyami: Dic. ... kand. med. nauk. M. 1996.
  30. Aizenstein H, Nebes R, Saxton J et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 2008;65(11):1509-1517. doi: 10.1001/archneur.65.11.1509
  31. Gold G, Giannakopoulos P, Herrmann F, Bouras C, Kövari E. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain. 2007;130(11):2830-2836. doi: 10.1093/brain/awm228
  32. McKhann G, Knopman D, Chertkow H, Hyman B, Jack C, Kawas C et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263-269. doi: 10.1016/j.jalz.2011.03.005
  33. Roman G, Tatemichi T, Erkinjuntti T et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurol. 1993;43(2):250-260. doi: 10.1212/wnl.43.2.250
  34. Levin O.S. Algoritmy diagnostiki i lecheniya dementsii. 7-e izd. M.: MEDpress-inform; 2014.
  35. Morris J. Clinical Dementia Rating (CDR): current version and scoring rules. Neurol. 1993;43(11):2412-2414. doi: 10.1212/wnl.43.11.2412-a
  36. Berg K, Wood-Dauphinee S, Williams J et al. Measuring balance in the elderly: validation of an instrument. Can J Public Health. 1992;83(2):7-11.
  37. Mioshi E, Dawson K, Mitchell J et al. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21:1078-1085. doi: 10.1002/gps.1610
  38. Nasreddine Z, Phillips N, Bédirian V et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699. doi: 10.1111/j.1532-5415.2005.53221.x
  39. Luriya A.R. Osnovy neiropsikhologii. Uchebnoe posobie dlya studentov vysshikh uchebnykh zavedenii. 4-e izd. M.: Akademiya; 2006.
  40. Lehfeld H, Erzigkeit H. The SKT - A Short Cognitive Performance Test for Assessing Deficits of Memory and Attention. Int Psychogeriatr. 1997;9(1):115-121. doi: 10.1017/s104161029700478x
  41. Alexopoulos G, Abrams R, Young R et al. Cornell Scale For Depression in Dementia. Biological Psychiatry. 1988;23:271-284. doi: 10.1016/0006-3223(88)90038-8
  42. Cummings J, Mega M, Gray K et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurol. 1994;44:2308-2314. doi: 10.1212/wnl.44.12.2308
  43. European Guidelines of CVD prevention in clinical practice: 3rd edition. Europ. J of CV Rrevention and Rehabilitation. 2003;10(1):1-72.
  44. Fazekas F, Kleinert R, Offenbacher H et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurol. 1993;43:1683-1689. doi: 10.1212/wnl.43.9.1683
  45. Wahlund L, Barkhov F, Fazekas F et al. A new rating scale for age-related white matter changes. Stroke. 2001;32(6):1318-1322. doi: 10.1161/01.str.32.6.1318
  46. Scheltens P, Launer L, Barkhof F, Weinstein H, van Gool W. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol. 1995;242:557-560. doi: 10.1007/bf00868807
  47. Yakhno N.N., Levin O.S., Damulin I.V. Sopostavlenie klinicheskikh i MRT-dannykh pri distsirkulyatornoi entsefalopatii. Kognitivnye narusheniya. Nevrologicheskii zhurnal. 2001;3:10-18.
  48. Hassan A, Hunt B, O’Sullivan M. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain. 2003;126:424-432. doi: 10.1093/brain/awg040
  49. Gregoire S, Chaudhary U, Brown M et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurol. 2009;73(21):1759-1766. doi: 10.1212/wnl.0b013e3181c34a7d
  50. Roman G, Kalaria R. Vascular determinants of cholinergic deficits in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2006;27(12):1769-1785. doi: 10.1016/j.neurobiolaging.2005.10.004
  51. Snowdon D, Greiner L, Mortimer J et al. Brain infarction and the clinical expression of Alzheimer's disease. The Nun Study. JAMA. 1997;277(10):813-817. doi: 10.1001/jama.277.10.813
  52. Frisoni G, Galluzzi S, Pantoni L, Filippi M. The effect of white matter lesions on cognition in the elderly - small but detectable. Nat Clin Pract Neurology. 2007;3(11):620-627. doi: 10.1038/ncpneuro0638
  53. Libon D, Price C, Giovannetti T et al. Linking MRI hyperintensities with patterns of neuropsychological impairment. Stroke. 2008;39:806-813. doi: 10.1161/strokeaha.107.489997
  54. Hommet S, Constans M. Review of Cerebral Microangiopathy and Alzheimer’s Disease: Relation between White Matter Hyperintensities and Microbleeds. Dement Geriatr Cogn Disord. 2011;32(6):367-378. doi: 10.1159/000335568
  55. Werring D, Gregoire S, Cipolotti L. Cerebral microbleeds and vascular cognitive impairment. J Neurol Sci. 2010;299:131-135. doi: 10.1016/j.jns.2010.08.034

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.